Sandra Roche

546 total citations
27 papers, 440 citations indexed

About

Sandra Roche is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Sandra Roche has authored 27 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Sandra Roche's work include Pancreatic and Hepatic Oncology Research (6 papers), HER2/EGFR in Cancer Research (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Sandra Roche is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), HER2/EGFR in Cancer Research (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Sandra Roche collaborates with scholars based in Ireland, United States and Denmark. Sandra Roche's co-authors include Martin Clynes, Robert O’Connor, Dermot F. Brougham, Tsedev Ninjbadgar, Christian Kerskens, Andreas Heise, Gillian McMahon, Britta Stordal, John Crown and Victoria McEneaney and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Sandra Roche

26 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Roche Ireland 12 207 193 74 65 56 27 440
Fiona H. Tan Australia 11 302 1.5× 150 0.8× 52 0.7× 108 1.7× 67 1.2× 20 591
N Yu Lukianova Ukraine 11 184 0.9× 148 0.8× 92 1.2× 48 0.7× 68 1.2× 66 447
Suzanne J. Bakewell United States 10 184 0.9× 282 1.5× 45 0.6× 34 0.5× 94 1.7× 19 520
Vincent A. de Weger Netherlands 11 211 1.0× 334 1.7× 67 0.9× 41 0.6× 38 0.7× 26 551
Cinzia Borghese Italy 16 265 1.3× 460 2.4× 95 1.3× 60 0.9× 117 2.1× 26 850
Peter Drückes Switzerland 9 262 1.3× 240 1.2× 33 0.4× 96 1.5× 86 1.5× 9 596
Saini Setua United States 12 248 1.2× 231 1.2× 78 1.1× 123 1.9× 51 0.9× 24 595
Haiyang Wang China 11 230 1.1× 262 1.4× 67 0.9× 48 0.7× 50 0.9× 23 553
Bryan T. Greene United States 10 205 1.0× 261 1.4× 75 1.0× 63 1.0× 53 0.9× 11 542
Aoife Devery United Kingdom 10 266 1.3× 183 0.9× 113 1.5× 56 0.9× 28 0.5× 15 480

Countries citing papers authored by Sandra Roche

Since Specialization
Citations

This map shows the geographic impact of Sandra Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Roche more than expected).

Fields of papers citing papers by Sandra Roche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Roche. The network helps show where Sandra Roche may publish in the future.

Co-authorship network of co-authors of Sandra Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Roche. A scholar is included among the top collaborators of Sandra Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Roche. Sandra Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conlon, Neil T., Sandra Roche, Laura Breen, et al.. (2024). Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo. Translational Oncology. 49. 102073–102073. 2 indexed citations
2.
3.
Roche, Sandra, Patricia Gaule, Nupur Mukherjee, et al.. (2023). Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer. PLoS ONE. 18(3). e0282512–e0282512. 6 indexed citations
4.
Roche, Sandra, et al.. (2023). Carbon Materials Prepared from Invading Pelagic Sargassum for Supercapacitors’ Electrodes. Molecules. 28(15). 5882–5882. 4 indexed citations
5.
Niu, Jin, Neil T. Conlon, Martin Clynes, et al.. (2022). FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures. The AAPS Journal. 24(6). 108–108. 2 indexed citations
6.
Conlon, Neil T., Justine Meiller, Sandra Roche, et al.. (2022). Pancreatic Cancer 3D Cell Line Organoids (CLOs) Maintain the Phenotypic Characteristics of Organoids and Accurately Reflect the Cellular Architecture and Heterogeneity In Vivo. Dublin City University Open Access Institutional Repository (Dublin City University). 1(2). 168–183. 2 indexed citations
7.
Redmond, Kelly M., Peter Smyth, Michelle K. Greene, et al.. (2020). DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models. Journal of Controlled Release. 324. 610–619. 20 indexed citations
8.
Henry, Michael, Sandra Roche, Niall Swan, et al.. (2020). Proteomic Analysis of Cell Lines and Primary Tumors in Pancreatic Cancer Identifies Proteins Expressed Only In Vitro and Only In Vivo. Pancreas. 49(8). 1109–1116. 5 indexed citations
9.
Roche, Sandra, Niall Swan, Yonglun Luo, et al.. (2020). Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development. Scientific Reports. 10(1). 2778–2778. 33 indexed citations
10.
Roche, Sandra, Jean Murphy, Niall Swan, et al.. (2020). Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients. International Journal of Molecular Sciences. 21(3). 962–962. 12 indexed citations
11.
Fantoni, Nicolò Zuin, Zara Molphy, George Mitrikas, et al.. (2020). Polypyridyl‐Based Copper Phenanthrene Complexes: Combining Stability with Enhanced DNA Recognition. Chemistry - A European Journal. 27(3). 971–983. 25 indexed citations
12.
Gaule, Patricia, Nupur Mukherjee, B. Corkery, et al.. (2019). Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells. Cancers. 11(4). 548–548. 19 indexed citations
13.
Conlon, Neil T., Martina S.J. McDermott, Brigid C. Browne, et al.. (2018). Pre-clinical evaluation of the PP2A inhibitor LB-100 for the treatment of lapatinib resistant HER2-positive breast cancer.. Journal of Clinical Oncology. 36(15_suppl). e13021–e13021. 1 indexed citations
14.
Roche, Sandra, Neil T. Conlon, Norma O’Donovan, et al.. (2017). Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models. PLoS ONE. 12(5). e0177058–e0177058. 3 indexed citations
15.
Balasubramanian, Sundaravadivel, Harinath Kasiganesan, Yuhua Zhang, et al.. (2015). Dasatinib Attenuates Pressure Overload Induced Cardiac Fibrosis in a Murine Transverse Aortic Constriction Model. PLoS ONE. 10(10). e0140273–e0140273. 28 indexed citations
16.
Ninjbadgar, Tsedev, Sandra Roche, Robert O’Connor, et al.. (2013). Stable Aqueous Dispersions of Glycopeptide‐Grafted Selectably Functionalized Magnetic Nanoparticles. Angewandte Chemie International Edition. 52(11). 3164–3167. 74 indexed citations
17.
Ninjbadgar, Tsedev, Sandra Roche, Robert O’Connor, et al.. (2013). Stable Aqueous Dispersions of Glycopeptide‐Grafted Selectably Functionalized Magnetic Nanoparticles. Angewandte Chemie. 125(11). 3246–3249. 3 indexed citations
18.
Roche, Sandra, Louise Sewell, Justine Meiller, et al.. (2012). Development, validation and application of a sensitive LC–MS/MS method for the quantification of thalidomide in human serum, cells and cell culture medium. Journal of Chromatography B. 902. 16–26. 10 indexed citations
19.
Breen, Laura, et al.. (2010). Modulation of P-gp expression by lapatinib. Investigational New Drugs. 29(6). 1284–1293. 18 indexed citations
20.
Roche, Sandra, Gillian McMahon, Martin Clynes, & Robert O’Connor. (2009). Development of a high-performance liquid chromatographic–mass spectrometric method for the determination of cellular levels of the tyrosine kinase inhibitors lapatinib and dasatinib. Journal of Chromatography B. 877(31). 3982–3990. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fiona H. Tan Breakdown of academic impact, for papers by N Yu Lukianova Breakdown of academic impact, for papers by Suzanne J. Bakewell Breakdown of academic impact, for papers by Vincent A. de Weger Breakdown of academic impact, for papers by Cinzia Borghese Breakdown of academic impact, for papers by Peter Drückes Breakdown of academic impact, for papers by Saini Setua Breakdown of academic impact, for papers by Haiyang Wang Breakdown of academic impact, for papers by Bryan T. Greene Breakdown of academic impact, for papers by Aoife Devery
Rankless by CCL
2026